No Picture
News

Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease

SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)– #ASCRS2021–Allegro Ophthalmics announces positive results of ex-U.S. Phase 2 trial of ALG-1007 for the treatment of dry eye disease; FDA acceptance of IND. […]

No Picture
News

ImmixBio Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

LOS ANGELES: LOS ANGELES, July 23, 2021 /PRNewswire/ — Immix Biopharma, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to … […]

No Picture
News

ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim

LOS ANGELES: LOS ANGELES, July 23, 2021 /PRNewswire/ — ImaginAb Inc, a market leading global biotechnology company, focused on developing next generation immuno oncology imaging agents and therapeutic radiopharmaceuticals (RPT), today announced the si… […]

No Picture
Nasdaq:OPNTUS6837501039

Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial res… […]

No Picture
News

CETY Announces a $500,000 Sales Order for Aries Linden Biosolids Gasification Facility for Q3 2021

COSTA MESA, Calif.: COSTA MESA, Calif., July 22, 2021 /PRNewswire/ — Clean Energy Technologies, Inc. (OTCQB: CETY), a low-carbon energy company focusing on products and solutions in the energy efficiency and environmental sustainability market, announ… […]